OverviewSuggest Edit

Rewalk Robotics is a medical device company that designs, develops and commercializes a walking system for people with lower limb disabilities. Its products include ReWalk Rehabilitation System and ReWalk Personal System. ReWalk Rehabilitation System allows walking, standing, sitting and the capacity to ascend/descend stairs in the rehab center environment. The ReWalk Personal System is designed for everyday use in a range of environments. It allows sitting, standing, and turning as well as offers the ability to climb and descend stairs.

TypePublic
Founded2001
HQBerlin, DE
Websiterewalk.com

Latest Updates

Employees (est.) (Dec 2018)58(-10%)
Revenue (FY, 2018)$6.5 M(-15%)
Share Price (Apr 2019)$3.8 (-3%)

Key People/Management at ReWalk Robotics Ltd

Larry Jasinski

Larry Jasinski

Board of Directors & CEO
Miri Pariente

Miri Pariente

VP of QA and Operations
Ofir Koren

Ofir Koren

Vice President of Research & Development
Ori Gon

Ori Gon

CFO
Loren Wass

Loren Wass

VP of Sales
Show more

ReWalk Robotics Ltd Office Locations

ReWalk Robotics Ltd has offices in Berlin, Marlborough and Yokne'am Illit
Berlin, DE (HQ)
15 Leipziger Pl.
Yokne'am Illit, IL
3 HaTnufa St
Marlborough, US
200 Donald Lynch Blvd, Marlborough
Show all (3)

ReWalk Robotics Ltd Financials and Metrics

ReWalk Robotics Ltd Revenue

Embed Graph
View revenue for all periods
ReWalk Robotics Ltd's revenue was reported to be $6.55 m in FY, 2018
USD

Revenue (Q2, 2019)

877.0k

Gross profit (Q2, 2019)

435.0k

Gross profit margin (Q2, 2019), %

49.6%

Net income (Q2, 2019)

(4.6m)

EBIT (Q2, 2019)

(4.2m)

Market capitalization (10-Apr-2019)

556.1k

Closing stock price (10-Apr-2019)

3.8

Cash (30-Jun-2019)

24.1m
ReWalk Robotics Ltd's current market capitalization is $556.1 k.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

3.7m5.9m7.8m6.5m

Revenue growth, %

57%

Cost of goods sold

3.5m5.1m4.7m3.7m

Gross profit

214.0k736.0k3.1m2.8m
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

2.1m817.0k1.4m2.5m2.0m1.7m1.6m1.8m1.6m1.6m877.0k

Cost of goods sold

1.6m732.0k1.1m1.5m1.3m1.0m897.0k1.0m855.0k655.0k442.0k

Gross profit

493.0k85.0k290.0k1.0m741.0k708.0k682.0k767.0k762.0k926.0k435.0k

Gross profit Margin, %

24%10%21%42%37%41%43%43%47%59%50%
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Cash

17.9m23.7m14.6m9.5m

Accounts Receivable

432.8m

Inventories

574.5k3.3m3.6m2.2m

Current Assets

23.8m29.5m20.9m13.2m
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(25.4m)(32.5m)(24.7m)(21.7m)

Depreciation and Amortization

438.0k696.0k642.0k463.0k

Inventories

(2.5m)(911.0k)(582.0k)1.4m

Accounts Payable

1.1m950.0k(1.6m)492.0k
USDY, 2019

Financial Leverage

1.9 x
Show all financial metrics

ReWalk Robotics Ltd Online and Social Media Presence

Embed Graph

ReWalk Robotics Ltd Blogs

ReStore Exo-Suit Robotic System

PROJECT TYPE Exo-suit with robotics system DEVELOPER ReWalk Robotics APPLICATION Clinic-based therapy system for gait rehabilitation after stroke SYSTEM WEIGHT 11lbs (5kg) Expand Previous The mechanical cables attached to legs and around the lower torso assist in providing plantar flexion and dorsif…

ReWalk Robotics to Present at the H.C. WAINWRIGHT Conference on September 9th

ReWalk Robotics to Present at the H.C. WAINWRIGHT Conference on September 9th Content Import Fri, 08/23/2019 - 16:05 ReWalk Robotics to Present at the H.C. WAINWRIGHT Conference on September 9th  — 08/23/19 This release is a backfill from a News Wire …

ReWalk Robotics Reports Second Quarter 2019 Financial Results

— 2019 second quarter total revenue of $0.9 million — — Received FDA & CE clearance for ReStore Exo-Suit — YOKNEAM ILIT, Israel / MARLBOROUGH, Mass. , Aug. 08, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the

ReWalk Robotics to Report Second Quarter 2019 Financial Results on August 8, 2019

ReWalk Robotics to Report Second Quarter 2019 Financial Results on August 8, 2019 Content Import Tue, 08/06/2019 - 01:43 ReWalk Robotics to Report Second Quarter 2019 Financial Results on August 8, 2019  — 08/06/19 This release is a backfill from a News Wire …

FDA approves ReWalk’s mobility device for stroke survivors

FDA approves ReWalk’s mobility device for stroke survivors. The post FDA approves ReWalk’s mobility device for stroke survivors appeared first on ReWalk – More Than Walking.

ReWalk Robotics Announces Pricing of Registered Direct Offering for $5 Million

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.  (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with institutional investors providing for the issuance of approximately 833,334 ordinary
Show more

ReWalk Robotics Ltd Frequently Asked Questions

  • When was ReWalk Robotics Ltd founded?

    ReWalk Robotics Ltd was founded in 2001.

  • Who are ReWalk Robotics Ltd key executives?

    ReWalk Robotics Ltd's key executives are Larry Jasinski, Miri Pariente and Ofir Koren.

  • How many employees does ReWalk Robotics Ltd have?

    ReWalk Robotics Ltd has 58 employees.

  • What is ReWalk Robotics Ltd revenue?

    Latest ReWalk Robotics Ltd annual revenue is $6.5 m.

  • What is ReWalk Robotics Ltd revenue per employee?

    Latest ReWalk Robotics Ltd revenue per employee is $112.8 k.

  • Who are ReWalk Robotics Ltd competitors?

    Competitors of ReWalk Robotics Ltd include ReSound, iHear Medical and Diamond Orthopedic.

  • Where is ReWalk Robotics Ltd headquarters?

    ReWalk Robotics Ltd headquarters is located at 15 Leipziger Pl., Berlin.

  • Where are ReWalk Robotics Ltd offices?

    ReWalk Robotics Ltd has offices in Berlin, Marlborough and Yokne'am Illit.

  • How many offices does ReWalk Robotics Ltd have?

    ReWalk Robotics Ltd has 3 offices.